Innovation and Biologics Demand in the US Plasma Fractionation Market
The United States represents the largest contributor to the plasma fractionation industry globally, supported by a well-established plasma collection infrastructure, advanced biopharmaceutical manufacturing capabilities, and a high adoption rate of plasma-derived therapies. The growing prevalence of primary immunodeficiency disorders, hemophilia, autoimmune diseases, and neurological conditions...
0 Commentarii 0 Distribuiri 57 Views 0 previzualizare